OCREVUS

OCREVUS (ocrelizumab) is a monoclonal antibody that helps the body’s immune system by targeting and destroying certain cells. This may help to protect healthy cells from damage. Specifically, it is a CD20-cytolytic antibody for the treatment of Multiple Sclerosis (MS).

For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.

OCREVUS REFERRAL FORM

What it treats

Multiple Sclerosis

Prescribed by

Neurologists

How it’s administered

Intravenous (IV) infusion

Frequency

Once every six months

Length of treatment

Five hours or more